POPULARITY
57 episodes with hss
38 episodes with hss
12 episodes with hss
13 episodes with hss
7 episodes with hss
6 episodes with hss
5 episodes with hss
8 episodes with hss
19 episodes with hss
4 episodes with hss
5 episodes with hss
5 episodes with hss
3 episodes with hss
2 episodes with hss
4 episodes with hss
5 episodes with hss
3 episodes with hss
3 episodes with hss
3 episodes with hss
4 episodes with hss
3 episodes with hss
3 episodes with hss
5 episodes with hss
3 episodes with hss
2 episodes with hss
47 episodes with hss
2 episodes with hss
William B. Coley started using a bacterial infection to treat cancers in the late 19th century, one of the earliest uses of immunotherapy. Research: Ahuja, Sana and Sufian Zaheer. “The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.” Korean Journal of Clinical Oncology 2024; 20(2): 51-73. DOI: https://doi.org/10.14216/kjco.24009 Atkins, Douglas. “Helen Coley Nauts: Advocate for Immunotherapy.” National Library of Medicine. 4/19/2016. https://circulatingnow.nlm.nih.gov/2016/04/19/helen-coley-nauts-advocate-for-immunotherapy/ Cancer Research Institute. “The History of Cancer Immunotherapy.” Coley, William B. “Therapeutic Value of the Mixed Toxins of the Streptococcus of Erysipelas and Bacillus Prodigiosus in the Treatment of Inoperable Malignant Tumors. With a Report of 160 Cases.” American Journal of the Medical Sciences. September 1896. College of Physicians of Philadelphia. “Cancer Vaccines and Immunotherapy.” History of Vaccines. https://historyofvaccines.org/vaccines-101/future-immunization/cancer-vaccines-and-immunotherapy/ Colley, William B. “The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).” Reprinted from the “ Proceedings of the Royal Society of Medicine,” November, 1909. London. John Bale, Sons & Danielsson, LTD. 1909. https://archive.org/details/b22425949/mode/1up Decker WK, da Silva RF, Sanabria MH, Angelo LS, Guimarães F, Burt BM, Kheradmand F and Paust S (2017) Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models. Front. Immunol. 8:829. doi: 10.3389/fimmu.2017.00829 Devaraja, K. et al. “Coley’s Toxin to First Approved Therapeutic Vaccine—A Brief Historical Account in the Progression of Immunobiology-Based Cancer Treatment.” Biomedicines 2024, 12, 2746. https://doi.org/10.3390/biomedicines12122746 Dobosz, Paula and Tomasz Dzieciatkowski.” The Intriguing History of Cancer Immunotherapy. Frontiers in Immunology. 12/17/2019. doi: 10.3389/fimmu.2019.02965 Hall, Stephen S. “A Commotion in the Blood: Life, Death, and the Immune System.” Henry Holt and Company. Excerpted at New York Times. https://archive.nytimes.com/www.nytimes.com/books/first/h/hall-commotion.html Harutyunyan, Mariam. “How William Coley Became The Father of Cancer Immunotherapy.” OncoDaily Magazine. 7/31/2026. https://oncodaily.com/magazine/william-coley-549446 Hiroaki Ikeda, Cancer immunotherapy in progress—an overview of the past 130 years, International Immunology, Volume 37, Issue 5, May 2025, Pages 253–260, https://doi.org/10.1093/intimm/dxaf002 Journal of the American Medical Association. “Erysipelas Toxins in the Treatment of Malignant Tumors.” 10/27/1894. Journal of the American Medical Association. “The Failure of the Erysipelas Toxins.” Vol 23 Iss 24. 12/15/1894. Kokolus, Katie. “The History of Immunotherapy: Toxins, Targets & T Cells.” LabRoots. 10/18/2021. https://www.labroots.com/trending/cancer/21449/history-immunotherapy-toxins-targets-cells?srsltid=AfmBOooP1eoVP2LbWKR5m-HLu1PSBFhOyPH1jSJWWcxvyK6EA4-hBu47 Levine, David B. “The Hospital for the Ruptured and Crippled: William Bradley Coley, third Surgeon-in-Chief 1925-1933.” HSS journal : the musculoskeletal journal of Hospital for Special Surgery vol. 4,1 (2008): 1-9. doi:10.1007/s11420-007-9063-2 McCarthy, Edward F. “The Toxins of William B. Coley and the Treatment of Bone and Soft-tissue Sarcomas.” The Iowa Orthopaedic Journal. Vol. 26. Memorial Sloan Kettering Cancer Center. “MSK Immunotherapy — Timeline of Progress.” https://www.mskcc.org/timeline/immunotherapy-msk National Library of Medicine. “Harnessing the Power of You: The History of Immunotherapy.” https://www.nlm.nih.gov/exhibition/the-history-of-immunotherapy/index.html Nauts, Helen Coley. “Coley’s Toxins – The First Century.” Townsend Letter for Doctors and Patients. June 2004. Nawrat, Allie. “Charting the history of immunotherapy, cancer treatment’s fourth pillar.” Pharmaceutical Technology. 7/28/2020. https://www.pharmaceutical-technology.com/features/charting-the-history-of-immunotherapy-cancer-treatments-fourth-pillar/?cf-view&cf-closed Oiseth SJ, Aziz MS. “Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead.” J Cancer Metastasis Treat. 2017;3:250-61. http://dx.doi.org/10.20517/2394-4722.2017.41 Tontonoz, Matthew. “What Ever Happened to Coley’s Toxins?.” Cancer Research Institute. 4/2/2015. https://www.cancerresearch.org/blog/what-ever-happened-to-coleys-toxins See omnystudio.com/listener for privacy information.
En este podcast respondo algunas de las preguntas que más me hacéis sobre fotografía, iluminación, objetivos y cómo ganarse la vida como fotógrafo profesional.Hablamos de si un flash pequeño realmente sirve para hacer retratos en exteriores y al atardecer, y de por qué la potencia del flash no lo es todo. Distancia al sujeto, modificadores, tamaño de la fuente de luz, ISO, HSS… hay muchas más variables de las que parece.También explico una duda muy habitual sobre medición puntual y medición matricial: qué ocurre después de calcular correctamente la exposición y por qué puedes cambiar el modo de medición sin cargarte la foto si estás trabajando en manual.Además, respondo a una comparación entre el Viltrox 56mm f/1.2 y el Viltrox 27mm f/1.2. Dos objetivos espectaculares, pero que no deberían elegirse simplemente preguntando cuál tiene “más calidad”. Antes de comprar un objetivo tienes que tener claro qué distancia focal necesitas y para qué tipo de fotografía o vídeo vas a utilizarlo.Y sí… también me caliento un poco respondiendo a un comentario sobre la publicidad y los patrocinadores del podcast. Después de años creando contenido gratuito cada semana, tenía algunas cosas que decir sobre este tema.Por último, hablamos de una de las excusas que más escucho entre quienes quieren dedicarse profesionalmente a la fotografía: “en mi ciudad el mercado está saturado”. Para mí, que haya competencia no significa que no haya oportunidades. La clave está en diferenciarte, entender marketing, aprender a vender y encontrar qué puedes ofrecer tú que los demás no están ofreciendo.Si quieres dedicarte a la fotografía profesional, mejorar tu técnica o entender mejor cómo funciona realmente este negocio, creo que este podcast te va a dar unas cuantas ideas.Déjame también tus preguntas en los comentarios porque pueden convertirse en protagonistas de próximos programas.#Fotografia #FotografoProfesional #IluminacionFotografica #FlashFotografia #Viltrox #MarketingParaFotografos #PodcastFotografia**COMPRA EN FOTOK desde este enlace y pon el cupón GABELLIFTK en tu carrito de la compra para llevarte un regalo.WEB FOTOK: https://fotok.es/?aff=y206___________________WEBS: https://www.rubengabelli.comhttps://fotografodecomida.esYOUTUBE: https://cutt.ly/ft3QEHF PATREON: https://www.patreon.com/RubenGabelli INSTAGRAM: @rubengabelli
This summer, join host David Mandell as he revisits and highlights episodes from Season 5 of The Wealth Planning for the Modern Physician podcast, in our 2026 Summer Rewind Series. "I genuinely believe there is a lot of information to gain from all of our episodes deliver, but for the summer, I've handpicked a few that offer intriguing ideas and a unique perspective for physicians in 2025," says David. "I hope you enjoy this Season encore series. Have a great summer!" Episode 5.18 | Originally Released: May 14, 2025 In this episode of the Wealth Planning for the Modern Physician podcast, host David Mandell sits down with two highly respected medical leaders—Dr. Mark Figgie, Chief Emeritus of the Surgical Arthritis Service at the Hospital for Special Surgery (HSS), and Dr. Joel Press, Physiatrist-in-Chief at HSS—to explore their personal and professional journeys in medicine. Dr. Press shares how his diverse early experiences led him to physiatry, while Dr. Figgie recounts his balance between science, business, and a lifelong pursuit of education, including earning an MBA during his fellowship. The conversation shifts into a discussion of mentorship at the Hospital for Special Surgery, where both physicians have played key roles in developing a cross-disciplinary mentorship model to support younger doctors. Their focus extends beyond clinical guidance to include career development, personal financial planning, and wellness—areas often overlooked in traditional medical training. This approach fosters institutional collaboration and a stronger culture at HSS. Finally, the episode dives into physicians' relationships with industry. Dr. Figgie offers candid advice on contracts, intellectual property rights, and ethical considerations when working with device manufacturers. He emphasizes the importance of legal review and staying true to what benefits patients. Dr. Press adds insight into personal financial trust, suggesting that doctors build a "board of directors" for trusted guidance. The episode closes with a preview of future initiatives aimed at supporting physicians earlier in their careers through financial education and mentorship. Learn more by visiting the original episode page. Learn more, including additional show notes, links, and detailed key takeaways, by visiting visiting the original episode page. Check out other episodes from our 6 seasons by visiting, physicianswealthpodcast.com. Click here to get your FREE copy of our latest book, Wealth Strategies for Today's Physician!
In this episode of HSS Presents, radiologist Dr. Harry G. Greditzer IV speaks with Dr. Andrew D. Pearle, Chief Emeritus of the Sports Medicine Institute at HSS, about the evolution of computer-assisted surgery and the emerging role of digital twins in orthopedics. Dr. Pearle explains how patient-specific MRI models, computational biomechanics, and additional data inputs may help clinicians assess ACL-injury risk, simulate surgical approaches, and personalize treatment planning. The conversation highlights neuromuscular training—a combination of strength, agility, plyometric, and landing-stabilization exercises—as an important strategy for reducing injuries among young athletes. Looking ahead, they also discuss how digital twins could support more individualized prevention, informed decision-making, and treatments designed around each patient's anatomy, movement patterns, and activity goals.
On this episode of Talking Guitars on Johnny Beane TV, we take a look at Charvel's brand-new Pro Plus Dinky DK24 models—four metal-focused guitars loaded with serious firepower, including Seymour Duncan Nazgul pickups, Floyd Rose tremolos, stainless-steel frets, and killer new finishes like Zombie Fade. Charvel has expanded the Pro Plus Dinky DK24 lineup with four new models designed for speed, precision, and heavy music. While these guitars are built for shredders, the pickup and hardware combinations make them especially interesting for modern metal players.
In this episode of HSS Presents, Dr. Scott Rodeo, Director of the Center for Regenerative Medicine at HSS, talks with sports medicine surgeon Dr. Yianni Apostolakos about the massive public interest and clinical realities surrounding Body Protection Compound 157 (BPC-157). Prompted by a widely read systematic review, the experts contrast promising preclinical animal data with the current lack of robust, human clinical trials. They discuss the shifting regulatory landscape—including recent FDA updates on compounding restrictions—and explain why these substances remain banned by WADA and major sports leagues. This conversation provides evidence for clinicians looking to ethically counsel both elite and recreational athletes on the use of these substances. Read the HSS Journal systematic review: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
Ich spreche darüber, warum ein neuer BambuLab oder der nächste FDM-Drucker selten der entscheidende Schritt für mehr Produktivität ist. Du erfährst, woran du erkennst, dass dein 3D-Druck bereits bereit für den nächsten Technologiesprung ist und welche Rolle Pulverbettverfahren dabei spielen. Eine Folge für alle, die additive Fertigung nicht nur anwenden, sondern wirtschaftlich skalieren möchten.
Heart failure remains one of the leading causes of hospitalization among older adults worldwide. During episodes of acute decompensated heart failure (ADHF), excess fluid builds up in the lungs and body, making breathing difficult and increasing the risk of serious complications. Although intravenous loop diuretics such as furosemide are the standard treatment for relieving congestion, many patients continue to experience persistent inflammation, ongoing cardiac remodeling, and worsening heart function despite therapy. A research paper published in Volume 18 of Aging titled “Effects of intravenous furosemide plus small-volume hypertonic saline solutions on inflammatory, remodelling markers and epigenetics signatures of patients with congestive acute decompensated heart failure (ADHF),” investigated whether combining intravenous furosemide with small volumes of hypertonic saline solution (HSS) could improve biological markers associated with heart failure compared with furosemide alone. Full blog post - https://aging-us.org/2026/08/hypertonic-saline-plus-furosemide-improves-heart-failure-biomarkers-in-randomized-trial/ DOI - https://doi.org/10.18632/aging.206364 Corresponding author - Antonino Tuttolomondo - bruno.tuttolomondo@unipa.it Abstract video - https://www.youtube.com/watch?v=EG65XlcDJ3U Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206364 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, heart failure, acute decompensated heart failure, furosemide, hypertonic saline solution To learn more about the journal, please visit https://www.Aging-US.com and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM
Fender Japan has done it again! The brand's new Limited Active Modern Series introduces some impressive innovations that many players have been asking for—and it raises one big question: Why aren't these features available on more U.S.-made Fenders? The new lineup includes two Stratocasters (SSS and HSS), a Telecaster, and a Modern Jazz Bass, all loaded with modern upgrades while staying true to classic Fender DNA. One of the biggest additions is the new Turbo Tone Boost. Activated with a push/push volume knob, it simulates the sound of a hotter single-coil pickup by electronically increasing the perceived winding effect—giving players a thicker, more powerful tone without changing pickups. Fender Japan also introduces a redesigned five-bolt neck heel, providing easier access to the upper frets while improving stability. The Stratocasters and Telecasters feature elegant body binding, a rare sight on production Fender Strats that gives these guitars a premium custom-shop vibe. Another standout feature is the new SILENCOIL system. Designed to eliminate hum while preserving the authentic tone and attack of traditional single-coils, it works independently from the pickups themselves—meaning players can swap pickups later and still keep the noiseless technology. Built with alder bodies, maple necks, premium fingerboards, and high-quality Japanese craftsmanship, the Active Modern Series blends vintage tone with modern performance. The guitars are available in finishes including Two-Color Sunburst, Feather Gray, Black, Sapphire Blue Transparent, and Vintage Natural. Unfortunately, there's one catch: the entire Active Modern Series is exclusive to Japan. Could these innovations eventually make their way to Fender's U.S. lineup? Many players are hoping so. What do you think? Would you buy one of these Fender Japan Active Modern guitars if they were available in the United States? #FenderJapan #FenderStratocaster #FenderTelecaster #ElectricGuitar
I discuss how the dooming never ends for those who can't see the bigger picture and the foundation that has been laid out for real accountability regarding treason and sedition in our elections and within our nation; I discuss recent examples of education fraud and how the AFT is involved in illegal voting and activism; HSS is losing 100 Billion in fraud; and a Flock camera website to track their locations. Substack: https://theamericanclassroom.substack.com/p/the-2020-election-operation DeFlock: https://maps.deflock.org/?lat=37.2652&lng=-96.9113&zoom=2.14 Book Websites: HERE and HERE. https://www.moneytreepublishing.com/shop PROMO CODE: “AEFM” for 10% OFF, or https://armreg.co.uk PROMO CODE: "americaneducationfm" for 15% off all books and products. (I receive no kickbacks). https://www.thriftbooks.com/ Q posts book: https://drive.proton.me/urls/JJ78RV1QP8#yCO0wENuJQPH
This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Mobility is foundational to life itself, yet musculoskeletal conditions quietly rob millions of people of the very movement that makes living worthwhile.Dr. Bryan Kelly, President and CEO of HSS, is leading a bold answer to that challenge. As the steward of the world's top-ranked orthopedic institution, now embarking on what he calls a Mobility Revolution, Dr. Kelly is expanding HSS far beyond its storied Manhattan campus.Through landmark partnerships with Deerfield Management, General Atlantic, Peloton, and beyond, HSS is building a global platform to unlock mobility for everybody, everywhere.Join us to discover how Dr. Kelly and the HSS team are leveraging cutting-edge innovation, data intelligence, and how his unwavering focus on the patient are redefining musculoskeletal health for generations to come. Let's go!Episode Highlights:HSS, founded in 1863, has grown into a world-leading musculoskeletal ecosystem spanning surgery, research, and rheumatology.Dr. Kelly, originally a music major, found his calling in orthopedics and built the nation's largest hip preservation service at HSS.HSS's bold new vision, "unlock mobility for every body, everywhere," targets the full care continuum from prevention to recovery.HSS is executing a four-concentric-circle growth strategy, physical expansion and a digital platform built on deep musculoskeletal data.Dr. Kelly and Deerfield Management launched a dedicated mobility venture fund targeting $400 million to $1 billion for musculoskeletal innovation.About our Guest:Dr. Bryan Kelly is the President & CEO, Surgeon-in-Chief Emeritus at HSS, which is the world leader in orthopedics, rheumatology and related disciplines. At the core of HSS is Hospital for Special Surgery, the largest academic medical center specialized in musculoskeletal health, founded in 1863. US News & World Report ranks HSS #1 in Orthopedics nationwide (past 16 consecutive years) and as a national leader in Rheumatology and a Best Hospital for Pediatric Orthopedics. HSS leadership spans patient care, research, education and innovation.Dr. Kelly and his more than 5,000 HSS colleagues are dedicated to the purpose of helping people get back to what they need and love to do, better than any other place in the world. To achieve this, he is focused also on advancing HSS as the best place for specialists in musculoskeletal health and all other team members to advance their careers.A world-renowned surgeon, scientist and educator specialized in sports medicine and hip preservation, Dr. Kelly arrived at HSS in 1996 with undergraduate and medical degrees from Brown University and Duke University. He completed his residency and two-year fellowship at HSS, followed by additional fellowships under the direction of Dr. Marc J. Philippon at University of Pittsburgh Medical Center and Dr. Herbert Resch at the Landeskliniken Hospital in Salzburg, Austria. He has spent much time collaborating with Professor Michael Leunig in Zurich, Switzerland and has established an exchange program for hip preservation trainees. Dr. Kelly completed his MBA at NYU Stern School of Business in 2019.Prior to assuming his role as President and CEO in 2023, Dr. Kelly served in several other leadership positions at HSS including Surgeon-in-Chief, Chief of the Sports Medicine Institute, and Chief of the Hip Preservation Service. He has a faculty appointment as Full Professor of Orthopedics at Weill Cornell Medical College and medical staff appointments at HSS and New York - Presbyterian Hospital. He has cared for several sports teams, serving as Head Team Physician for the New York Rangers, Assistant Team Physician for the New York Giants and Orthopedic Consultant for UFC.Over the past 20 years and with over 200 peer reviewed scientific publications, Dr. Kelly has played an instrumental role in the evolution and maturation of the field of hip preservation, which helps people of all ages with non-arthritic hip disorders to maintain mobility and stability. In 2010, he started the Hip Preservation Service at HSS, which is now the nation's largest with a 12-year record of fellowships.Dr. Kelly has a broad range of both clinical and basic science research interests including the development of a clinical outcomes registry; biomechanical studies evaluating conflict patterns in femoroacetabular impingement and techniques in labral refixation; development of synthetic scaffolds for labral reconstruction and cartilage injuries in the hip; and the development of novel surgical techniques for managing soft tissue injuries around the hip joint.More information about HSS can be found at HSS.edu.Links Supporting This Episode: HSS website: CLICK HEREDr. Bryan Kelly LinkedIn page: CLICK HEREHSS LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE
In this episode of HSS Presents, residents Dr. Mark Megerian and Dr. Austin Kaidi host an insightful conversation with HSS orthopedic trauma surgeon Dr. Aleksey Dvorzhinskiy to explore the vital role of mentorship in surgical training. Dr. Dvorzhinskiy reflects on the ideological frameworks passed down by his own influential mentors, focusing on the core pillars of being morally incorruptible, pursuing technical excellence, and suppressing ego in the operating room. The panel dives into the nuances of surgical instruction, discussing how effective mentors distinguish between "tough love" and encouragement based on a resident's intrinsic motivation. Blending perspectives from a junior resident, a chief resident, and an attending, this episode offers a thoughtful roadmap on how to actively engage as a mentee and successfully transition into a surgical leader.
In this episode of HSS Presents, orthopedic resident Dr. Tyler Khilnani sits down with Dr. Samuel A. Taylor, a sports medicine orthopedic surgeon at HSS and associate team physician for the New York Giants. Drawing from his own background as a former Harvard varsity football player, Dr. Taylor pulls back the curtain on the intense, year-round responsibilities of caring for elite athletes. From navigating the high-stakes environment of the NFL Combine to managing evolving game-day injuries on the sidelines, he highlights the critical role of communication in a multidisciplinary sports medicine team. Ultimately, Dr. Taylor discusses the balancing act between clinical practice, resident education, and family life, offering invaluable advice for trainees aspiring to enter the field of team coverage.
In this episode of HSS Presents, orthopedic surgery resident Dr. Mark Megerian sits down with Dr. Mark Figgie, a hip and knee replacement surgeon who has spent four decades at HSS advising residents, fellows, and attendings as they transition to practice. Dr. Figgie shares practical guidance on evaluating a first job, from leveraging the HSS alumni network and vetting potential partners to reading the fine print on buy-in structures, non-compete clauses, and malpractice tail coverage. They also discuss how to negotiate for specific technology, approach salary conversations without alienating a prospective employer, and weigh private versus academic career paths.
Iedereen kent afwijzingsgevoeligheid. We willen allemaal ergens bij horen. Maar wat als die angst voor afwijzing je keuzes, grenzen, werkgeluk en zichtbaarheid gaat bepalen?In deze aflevering spreek ik met Saskia Klaaysen, HSP/HSS-coach, trainer, opleider en auteur van de bestseller Prikkels bijten niet!. We hebben het over rejection sensitivity: afwijzingsgevoeligheid die kan ontstaan wanneer je steeds opnieuw ervaart dat je afwijkt van de norm. Dat zie je vaak bij neurodivergente mensen, zoals HSP's, HSS'ers, mensen met ADHD, autisme, hoogbegaafdheid of dyslexie. Maar het kan bij iedereen ontstaan, bijvoorbeeld door opvoeding, trauma of het gevoel dat jouw manier van zijn “niet klopt”.Saskia legt uit hoe rejection sensitivity zich laat zien via sociale triggers (hoor ik erbij?) en prestatietriggers (doe ik het goed genoeg?). We bespreken waarom mensen gaan pleasen, perfectionistisch worden of zichzelf kleiner maken en wat dat doet met werkgeluk en met het benutten van neurodivergente talenten op de werkvloer.De oplossing is geen quick fix. Volgens Saskia gaat het om zelfacceptatie, zelfcompassie, oude coping doorbreken en stap voor stap meer zichtbaar worden. Luister mee als je wilt ontdekken hoe je uit de houdgreep van afwijzingsgevoeligheid kunt bewegen en meer ruimte maakt voor jezelf, je behoeften en je talenten.Volg Saskia op LinkedIn of Instagram.Bestel Saskia's boek ‘Prikkels bijten niet: https://anahatatraining.kennis.shop/pay/prikkelsnlMeer over de online masterclasses Rejection Sensitivity: Anahata Coaching & Training
BUFFALO, NY — April 7, 2026 — A new #research paper was #published in Volume 18 of Aging-US on March 26, 2026, titled “Effects of intravenous furosemide plus small-volume hypertonic saline solutions on inflammatory, remodelling markers and epigenetics signatures of patients with congestive acute decompensated heart failure (ADHF).” Led by first author Mario Daidone from University Hospital, Policlinico, Paolo Giaccone, and the University of Palermo, with corresponding author Antonino Tuttolomondo from University Hospital, Policlinico, Paolo Giaccone, and University of Palermo, the randomized trial compared i.v. furosemide plus small-volume hypertonic saline solution (HSS) with i.v. furosemide alone in patients with acute decompensated heart failure due to reduced ejection fraction. The study enrolled 200 subjects, randomly assigning 107 to furosemide plus HSS and 93 to furosemide alone. The authors found that patients treated with i.v. furosemide plus HSS showed lower increases in inflammatory and remodeling biomarkers after saline load, including IL-6, hsTnT, sST2, galectin-3, and NT-proBNP, and the intervention was associated with reduced miR181b expression compared with furosemide alone. These findings suggest that adding small-volume hypertonic saline to loop diuretic therapy may influence both circulating biomarkers and miRNA-related epigenetic signatures in acute heart failure. “Nevertheless, the possible effects of the i.v. furosemide + HSS treatment on natriuretic and inflammatory markers of heart failure deserve further confirmation, whereas the effects of this type of treatment on epigenetic signatures of pathologic mechanisms involved in the left ventricular dysfunction involved in AHF pathogenesis seem to be still not studied.” The authors note that this was a randomized trial in a specific ADHF population, so additional studies will be needed to confirm the durability of the biomarker changes, define the optimal patient groups, and determine whether these molecular effects translate into improved clinical outcomes. Future work may also clarify how the saline strategy interacts with cardiac remodeling and miRNA regulation in larger and more diverse heart failure cohorts. DOI - https://doi.org/10.18632/aging.206364 Corresponding author - Antonino Tuttolomondo - bruno.tuttolomondo@unipa.it Abstract video - https://www.youtube.com/watch?v=EG65XlcDJ3U Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206364 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, heart failure, acute decompensated heart failure, furosemide, hypertonic saline solution To learn more about the journal, please visit https://www.Aging-US.com and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM
Hrvatski predsjednik Milanović ne želi srbijanskog kolegu Vučića u Hrvatskoj, otkazao je regionalni summit Brdo-Brijuni. Premijer Plenković na korak je do još jedne saborske ruke, po svemu sudeći u većinu ulazi HSS. Za tradicionalnu uskrsnu prehranu četveročlanoj obitelji treba 164 eura.
Our guest this week is a Surfer, skater, snowboarder, and HSS alumni, turned 6-time Emmy nominee and 2-time Emmy Award-winning director. His work spans film, television, and global brand storytelling. He's collaborated with heavy hitters like FX, Netflix, Apple Music, as well as iconic brands including Porsche, Nike, Levi's, Microsoft, and Disney. His creative range even extends into music videos, working with legends like Tom Petty and cutting-edge artists like XG.He directed narrative pieces for the Olympic Channel's Game Breakers, and has shadow directed on major productions like The Politician and the Emmy nominated, Producers Guild Award winning series Shōgun. Now he's bringing that vision to his latest project, Lotus Point, a homage to 90's Surf and Skate culture, inspired by classics like North Shore, Point Break, Thrashin', Rad, Gleaming the Cube, The Goonies, and more. We're fired up to dive into his journey, his creative process, and what's next, we welcome to the show Mr. Joel Kazuo Knoernschild.
Cheesy and Fondue learn about non-dairy cheese. We talk about ancient fermented tofu. We find out about alternates to milk like rice, mealworms, seaweed and AI produced casein. And of course, we tell a very cheesy joke!Find us at www.justcheesy.com and everywhere you enjoy social media! https://linktr.ee/JustCheesy***Newsly is the sponsor of this episode! Go to https://newsly.me to download the free app and listen to articles, podcasts and digital radio! Get a FREE 1-Month Premium Subscription by using promo code CHEESY. Start listening today! *** Why is cheddar the most dangerous of all the cheeses? Because it is very sharp! Show Notes https://phys.org/news/2026-03-rice-based-cheese-possibility.htmlhttps://www.soyinfocenter.com/HSS/fermented%20_tofu1.phphttps://pubmed.ncbi.nlm.nih.gov/11322691/https://www.rimping.com/blog/7505/vegan-cheese-historyhttps://phys.org/news/2023-10-ancient-technology-plant-based-cheese.htmlhttps://modernfarmer.com/2023/08/the-future-of-cheese/https://www.dairyreporter.com/Article/2023/06/27/how-climax-foods-ai-produced-casein-could-spell-a-new-frontier-for-plant-based-cheese/https://vegnews.com/climax-foods-plant-based-caseinhttps://www.treelinecheese.comhttps://rebelcheese.com/collections/shop-all-products?srsltid=AfmBOopyG-R_OZUsMxtK7s_4WDmmGqGVQ57xR5Q2gsWTGRQBnCnv0A_C&page=2https://thevreamery.com/?srsltid=AfmBOooSzjZa-wBB6ytddJzacS9ISgLjFFzDFoYvRnqlVG-2mGDgCl7_
Send a textIs being inactive more dangerous than we think? In this clip from our episode “Why Exercise Beats Longevity Hacks”, CareTalk host John Driscoll speaks with Dr. Jordan Metzl, Author of The Athlete's Book of Home Remedies, about why movement may be the most powerful preventive medicine we have, even in the era of GLP-1s.Listen to the full episode here
We get a lot questions from our listeners each week and they're great questions,so rather than responding individually we thought we'd do these mini episodes where highlight some of the best questions and our responses. So, let's get started! Today's Ask The Sports Docs focuses on timing of ACL reconstruction surgery. Our patients, and their families, frequently ask… how long can I wait tohave the surgery? To answer that question, we're going to review an article, hot off the press in this month's issue of AJSM titled “Early ACL Reconstruction Mitigates the Development of Posttraumatic Osteoarthritis in a Murine ACL Rupture Model.” Dr. Julia Retzky and colleagues at HSS sought to answer the question:Does the timing of ACL reconstruction actually matter for long-term joint health?This is a timely paper because posttraumatic osteoarthritis or “PTOA” after ACL injury remains a massive unsolved problem. Even with modern reconstruction techniques, we're still seeing 23 to 60% rates of PTOA at 10 to 25 years post-op. Historically, the literature on timing is all over the place. Some studies suggest early ACLR may reduce PTOA risk, others show no difference. The problem isheterogeneity—different grafts, definitions of “early,” imaging versus radiographic OA, meniscal status, you name it.And that's where this paper is interesting. It strips away a lot of clinical confounders by using a controlled murine model (or mouse model) with a noninvasive closed ACL rupture, followed by either immediate reconstruction, delayed reconstruction, or no reconstruction. And importantly, this is the first murine study using a true intra-articular ACL reconstruction model, rather than extra-articular stabilization. So this mirrors what we do clinically, with a true anatomic ACL reconstruction.So, let's dive in...
Send us a textThe longevity boom is full of supplements, hacks, and expensive routines, but most of it ignores the simplest lever we already know works. If movement is the most studied “drug” for healthy aging, why are so many people still stuck on the sidelines?Dr. Jordan Metzl, Author of The Athlete's Book of Home Remedies joins CareTalk host John Driscoll, Chairman of UConn Health, to discuss why exercise is the most powerful prescription for healthspan, how motivation can be built through practical behavior change, and how strength and community can help prevent chronic disease over the long run.
In this episode of HSS Presents, physical therapist Snehal Patel sits down with Dr. Riley Williams, Chief of the Sports Medicine Institute at HSS, and Michael Chronert from DARI Motion to talk about the future of motion capture in patient care. They discuss how DARI's AI-driven tech is changing the game by offering a quick, markerless way to analyze movement without needing a full biomechanics lab. Dr. Williams explains how swapping manual exams for this kind of objective data—measuring things like limb symmetry and loading—leads to smarter "return to sport" decisions. It's a great look at how the field is moving from simple observation to high-tech precision to get athletes back in the game safely.
In this episode of HSS Presents, rheumatologist Dr. Caroline Siegel is joined by HSS colleagues Dr. Lisa Samaritano and Dr. Jane Salmon to discuss managing pregnancy for patients with autoimmune rheumatic diseases. They emphasize that most patients have successful pregnancies, but conditions like systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) carry greater risks, including preeclampsia and placental insufficiency. Successful outcomes rely on preconception planning, which includes achieving quiescent disease for about six months on pregnancy-compatible medications and screening for antibodies. Dr. Salmon also shares exciting clinical trial results using a TNF inhibitor to improve pregnancy outcomes in high-risk APS patients.
On this episode of DGTL Voices, Ed interviews Justin Oppenheimer, EVP of Hospital for Special Surgery (HSS). They discuss Justin's personal journey, including his athletic background, pivotal life lessons, and the importance of family values. Justin shares insights on his career at HSS, the evolution of leadership, and the impact of technology and AI in healthcare. The conversation emphasizes the significance of helping others and finding one's purpose in life.
Welcome to GamePlan with the Sports Docs. On each of these mini episodes, we chat about a new article or new surgical technique in the field of sports medicine. We'll give you our quick take on the most recent data and how this data will be impacting our practice.Today, we're talking about hamstring injuries in the NFL. And if your fantasy team is anything like my fantasy team, it currently looks like an infirmary. So, you'll probably want to listen in to this episode.Now, we've covered hamstring injuries in the NFL before. Last year we did an entire Game Plan episode dedicated to this topic. That is episode #52 if you want to check it out. Today, we are actually reviewing a new study just published this month in AJSM that focused on how player characteristics, injury severity and imaging findings can impact the amount of time missed as well as risk of recurrent injury. The article is titled “Correlation of Player and Imaging Characteristics with Severity and Missed Time in the National Football League Professional Athletes with Hamstring Strain Injury.” Molly Day, Scott Rodeo and team at HSS published this retrospective cross-sectional study that aimed to identify certain player characteristics, clinical examination findings and MRI results that were associated with injury severity and missed playing time. As always, links to all of the papers that we discuss on this show can be found on our podcast website – www.thesportsdocspod.com
This week, we're diving into some major Peloton fitness news. Is Peloton really integrating ChatGPT into the platform? We discuss what that could mean for your workouts and the future of connected fitness. Plus, we break down the new Breathwrk feature, a sweet apparel discount for our Canadian friends, and a huge new perk for Club Peloton members.Unfortunately, it wasn't all good news. Peloton was hit by a recent AWS outage, and we'll fill you in on what that meant for your classes. The company is also trying to get an investor lawsuit tossed out. On the instructor front, we have an important health update from Selena Samuela and some exciting news about Jess King. We also finally reveal last week's mystery instructor apparel collaboration.We're also talking about major legal battles in the fitness wearable world as Whoop sues Polar and Suunto sues Garmin. What does this mean for the future of fitness trackers? All this, plus our TCO Top Five favorite fitness classes of the week.Peloton is exploring an integration with ChatGPT. What could this mean for the future of Peloton fitness?Peloton adds Breathwrk meditation content to its lineup.A new Club Peloton discount is available for the Canadian apparel site.Club Peloton members get a significant new perk.The recent AWS outage affected Peloton services.Peloton files a motion to dismiss a pending investor lawsuit.Instructor Selena Samuela shares her gestational diabetes diagnosis.Jess King is set to DJ for Diplo's run club.Last week's mystery instructor apparel collaboration is revealed.The latest Artist Series features the music of Jorja Smith.Wearable tech drama: Whoop is suing Polar.And in more legal news, Suunto is suing Garmin.Bodi announces a new partnership with Tony Horton & P9X.The TCO Top Five: We recap the community's favorite Peloton classes of the week.This Week at Peloton: A look at the upcoming schedule.TCO Radar: Classes we are excited to take.A look at Peloton's special Halloween fitness classes.Peloton partners with HSS for new injury prevention classes.Jess Sims hosts her first Run Club class.Peloton Birthdays: Happy Birthday to Matt Wilpers (10/24) and Emma Lovewell (10/25)!Join The Clip Out community!Subscribe to our newsletter and find all our links at theclipout.com.Leave us a review on Apple Podcasts or Spotify See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode of HSS Presents, anesthesiologist Dr. Jeffrey Ciccone speaks with physiatrist and pain management specialist Dr. Faye Rim about preventing the transition from acute to chronic pain after surgery. They explore risk factors such as inflammation, central sensitization, opioid tolerance, and psychosocial influences, while highlighting the importance of proactive screening and multimodal pain strategies. Dr. Rim shares how HSS's transitional pain service identifies high-risk patients, coordinates perioperative care, and incorporates novel therapies—including ketamine infusions, nerve catheters, and new sodium channel blockers. The conversation emphasizes early intervention, individualized treatment, and system-level changes to improve recovery and reduce long-term disability.
In this episode of HSS Presents, rheumatologist Dr. Anne Bass is joined by Dr. Deanna Jannat-Khah of HSS and Dr. Michael Postow of Memorial Sloan Kettering to explore immune checkpoint inhibitor–induced arthritis. They discuss how life-saving immunotherapies for cancer can trigger inflammatory joint disease, the challenges of balancing tumor control with autoimmune toxicity, and the latest evidence on safe use of steroids and biologics. The panel also highlights ongoing research into mechanisms, phenotypes, and long-term outcomes, underscoring the importance of multidisciplinary care for cancer patients who develop musculoskeletal complications from immunotherapy.
In this episode, we're going to continue our discussion with Dr. Travis Matheney and focus on surgical treatment options for borderline hip dysplasia.Our conversation picks back up with a review article published in the December 2024 issue of Current Reviews in Musculoskeletal Medicine titled “Borderline Hip Dysplasia - Best Treated with Hip Arthroscopy or Periacetabular Osteotomy?” Dr. Andrea Spiker and colleagues summarized the current research comparing isolated hip arthroscopy to periacetabular osteotomy for patients with borderline hip dysplasia. They noted improved postoperative clinical outcome scores and low rates of conversion to total hip arthroplasty in both groups. The authors concluded that successful clinical outcome seem to rely on treating underlying clinical pathology as well as appropriate surgical indications and surgical techniques.Then, from the April 2021 issue of OJSM, we review an article titled “Comparison Between Hip Arthroscopic Surgery and Periacetabular Osteotomy for the Treatment of Patients With Borderline Developmental Dysplasia of the Hip.” This systematic review authored by Dr. Marc Philippon and his team at the Steadman Clinic in Vail found that outcomes improved across all patient reported outcome measures whether patients were treated using arthroscopic surgery or PAO. They noted that revision surgery was also common in both procedures. We finish up with an article from the September 2017 issue of AJSM titled “Early Functional Outcomes of Periacetabular Osteotomy After Failed Hip Arthroscopic Surgery for Symptomatic Acetabular Dysplasia.” Bryan Kelly and his team at HSS investigated the effect of prior arthroscopic hip surgery on clinical outcomes after periacetabular osteotomy or “PAO”. They found that patients who previously underwent hip arthroscopy had inferior functional outcomes at 6 months and 12 months after PAO compared to patients with no prior hip surgery. The authors note that both groups significantly improved post-op and there was no difference in complications or reoperation between the groups.
Trump v Omar. HSS fraud was reported to the state more than two years ago and nothing was done about it. Everyone in the state is justified in wondering how high this fraud actually goes. Johnny Heidt with guitar news. Heard On The Show:Riding the Gold Line: Nearly empty buses the normFormer KSTP-TV anchor Stan Turner dies after battle with cancerWhat to know about the H-1B visa Trump has targeted with $100,000 fees, generating confusion, fearSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Illinois Governor JB Pritzker reacts to breaking news that Disney's ABC television network has capitulated to strong-arming by the Trump administration to remove Jimmy Kimmel from the air, and encourages Americans to not only push back on Disney, but to remain steadfast in standing up to Donald Trump's intimidation tactics. Former federal prosecutor Preet Bharara weighs in on the legal perspective, and Rep. Dan Goldman joins to discuss Donald Trump's power overreach.Jen Psaki reports on a Senate health committee hearing in which Republicans were trapped trying to maintain the Trump administration's anti-vaccine attitude in the face of well-informed testimony from former CDC officials, including Republican-confirmed former CDC Director Susan Monarez, pushed out by Trump's HSS secretary, Robert F. Kennedy Jr. Dr. Debra Houry, the CDC's former chief medical officer, who also testified at today's hearing, joins to discuss the lack of scientific rigor and transparency from Trump's new health officials. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
In this episode of HSS Presents, rheumatologist Dr. Genna Braverman hosts a conversation with Dr. Arthur Yee and cardiologists Dr. Evelyn Horn and Dr. Irina Sobol on the interplay between the heart and rheumatic diseases. They discuss how conditions like sarcoidosis and scleroderma can affect the myocardium, valves, conduction system, and pulmonary vasculature—leading to heart failure, arrhythmias, and pulmonary hypertension. The panel highlights advances in imaging, from cardiac MRI to PET scans, and evolving treatments that combine immunosuppression, device therapy, and guideline-directed cardiac care. With insights into the new Cardio-Rheumatology Program at HSS and Weill Cornell, listeners will hear how collaboration between specialties is improving outcomes for patients with autoimmune diseases that affect the heart.
The Big Unlock · Digital Twins Could Be a Game-Changer for Scalable Healthcare Innovation – Podcast with Inderpal Kohli In this episode, Inderpal Kohli, Healthcare Executive Leader (Englewood Health, HSS, and Columbia University Medical Center), shares his vision for scalable digital health transformation. He outlines a proven framework focused on patient engagement, clinically integrated care, and remote patient monitoring—strategies that have already driven an 18–20% increase in online scheduling and improved outcomes in preventive care campaigns. Inderpal also reflects on how a chance project in biomedical informatics sparked his passion for digital transformation, leading to pioneering work in digital pathology, remote monitoring, and digital front door solutions. He explores the promise of ambient documentation in reducing clinician burden and enhancing satisfaction, and addresses the persistent challenge of integrating EHR systems with third-party tools—stressing the importance of seamless integration for meaningful impact. He also discusses the potential of digital twins as a game-changer, shares lessons on building agile, consumer-focused digital teams, and weighs in on how GenAI and agentic automation are poised to reshape care delivery. Take a listen.
Trump weighs in on Sydney Sweeney being a registered GOP and a new track from the AI Overlords. Plus, HSS gets shut down after fraud investigations, and Foes of the show go full racist.
The Big Unlock Podcast · AI If Done Right Can Rehumanize Healthcare – Podcast with Ashis Barad In this episode, Ashis Barad, Chief Digital Technology Officer at the Hospital for Special Surgery (HSS), discusses his journey in rehumanizing healthcare through digital health transformation. A practicing pediatric gastroenterologist, Ashis advocates for tech that genuinely solves problems, viewing himself as a “doctor first, technologist second.” Ashis stresses on Agentic AI and change management as pivotal elements in healthcare transformation. Healthcare is inherently workflow-centric, not a series of isolated moments. Barad explains Agentic AI as a workflow orchestrator designed to reduce administrative waste, enhance patient experience, and accelerate the adoption of best practices. Ashis outlines HSS's strategy to leverage its specialized focus to build a modern data lakehouse architecture and deploy AI-powered solutions through key partnerships. He envisions rehumanizing healthcare by automating backend processes, expanding clinician-patient time, and codifying best practices that can be scaled globally, especially in musculoskeletal care and movement. Take a listen.
Mike Welch tournament director for the 3M Open taking place next week. Get your tickets hereFeds execute search warrants connected to ‘massive scheme to defraud' a Minnesota housing programAlpha News was on location as a search warrant was being served at several locations related to a “massive scheme to defraud” Medicaid and Minnesota's Housing Stabilization Services (HSS) program.According to the search warrant, the fraud investigation involves HSS providers who billed for various services intended to provide stable housing for Minnesotans.The search warrant states, “The Program has proved to be extremely vulnerable to fraud.”The vulnerability stems from limited requirements for service providers and the vast services they can provide for Medicaid reimbursement.“Since Minnesota became the first state to offer Medicaid coverage for Housing Stabilization Services, dozens of new companies have been created and enrolled in the program. These companies, and the individuals who run them, have taken advantage of the housing crisis and the drug addiction crisis in Minnesota to prey on individuals who need help getting back on their feet as they recover from drug addiction,” the warrant says.“These companies and individuals do so by contacting Medicaid-eligible people in halfway houses and residential drug treatment facilities and offering to help them find stable housing. After registering these people to receive housing stabilization services, the companies fraudulently claim to provide dozens of Program service hours to their new ‘clients.' In reality, client after client has reported that they received little or no actual services or assistance from these companies. But the companies engaged in this scheme have received millions of dollars in Medicaid funds for housing stabilization services they did not actually provide,” it continues.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Mike Welch tournament director for the 3M Open taking place next week. Get your tickets hereFeds execute search warrants connected to ‘massive scheme to defraud' a Minnesota housing programAlpha News was on location as a search warrant was being served at several locations related to a “massive scheme to defraud” Medicaid and Minnesota's Housing Stabilization Services (HSS) program.According to the search warrant, the fraud investigation involves HSS providers who billed for various services intended to provide stable housing for Minnesotans.The search warrant states, “The Program has proved to be extremely vulnerable to fraud.”The vulnerability stems from limited requirements for service providers and the vast services they can provide for Medicaid reimbursement.“Since Minnesota became the first state to offer Medicaid coverage for Housing Stabilization Services, dozens of new companies have been created and enrolled in the program. These companies, and the individuals who run them, have taken advantage of the housing crisis and the drug addiction crisis in Minnesota to prey on individuals who need help getting back on their feet as they recover from drug addiction,” the warrant says.“These companies and individuals do so by contacting Medicaid-eligible people in halfway houses and residential drug treatment facilities and offering to help them find stable housing. After registering these people to receive housing stabilization services, the companies fraudulently claim to provide dozens of Program service hours to their new ‘clients.' In reality, client after client has reported that they received little or no actual services or assistance from these companies. But the companies engaged in this scheme have received millions of dollars in Medicaid funds for housing stabilization services they did not actually provide,” it continues.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode of HSS Presents, Dr. Peter Sculco, MD, sits down with Dr. Amar S. Ranawat, MD, to talk about the future of robotics in revision joint surgery. With decades of experience in complex hip and knee revisions, Dr. Ranawat shares why he continues to rely on manual techniques and outlines the key principles behind successful outcomes. They discuss the current limitations of robotic systems in revision cases, the importance of restoring the joint line, and the critical role of expert surgical teams. The episode also looks ahead to emerging technologies, from AI-driven planning to smarter robotic tools, that could reshape how complex joint reconstructions are performed. To learn more about The Stavros Niarchos Complex Joint Reconstruction Center at HSS, visit our HSS webpage and our X account.
In this final episode of Season 5, host David Mandell recaps the season's key themes and previews the upcoming Summer Rewind series, which will highlight standout episodes from Seasons 3 and 4. The podcast will continue on a biweekly schedule over the summer, with new introductions to previously released episodes, allowing listeners to revisit valuable content over the Summer. David reviews each of the 18 episodes of Season 5, including a quick recap and highlights. The goal of this episode is to help listeners catch up on missed episodes or revisit important insights they may have forgotten. He invites feedback and topic suggestions for future episodes as the podcast continues to grow its audience. EPISODE SNAPSHOTS: 5.1 & 5.2 – Dr. Jay Foley: After a life-altering snowboarding accident, Dr. Foley transitioned from surgery to medico-legal consulting, highlighting the importance of disability insurance and leveraging a medical license in new ways. 5.3 – Andy Taylor: Explored how election cycles influence market behavior and how physicians can remain calm and strategic with their portfolios. 5.4 – Nolan Bradbury, CPA: Covered KPIs, practice delegation, legal/tax structure for side hustles, and exit planning from a CPA's perspective. 5.5 – Dr. Ben Ostrander: Applied hospitality industry lessons to healthcare to enhance patient experience, employee satisfaction, and operational efficiency. 5.6 – Jessica Jones, Consultant: Shared insights on aligning practice models with physician passion, wellness trends, and diversification within practices—especially cash-based models. 5.7 & 5.8 – Dr. Sue Keller: An unflinching look at financial mismanagement, the emotional toll of bankruptcy, and finding meaning in a reinvented career after decades in dentistry. 5.9 – Dr. Jay Zigmont: Introduced “child-free wealth” as a growing financial niche, challenging traditional planning assumptions and offering guidance tailored to child-free individuals. 5.10 – Dr. Jude Pierre (Pt. 1): Talked about geographic and specialty shifts, mentorship, and the creation of a physician coaching practice to fight burnout and debt. 5.11 – Carole Foos & Greg Heimkreiter, CPAs: Discussed looming tax law expirations, industry-wide challenges in accounting services, and what physicians should know about finding quality tax advisors. 5.12 – Kristy LaGourgue & Rachel Varga: Focused on brand building and marketing strategy for all doctors, not just those in aesthetics—emphasizing the importance of digital presence and patient communication. 5.13 – Dr. Pat St. Pierre: Reflected on a military-to-medicine career, financial planning, industry involvement, and proactive retirement through wine education to avoid post-retirement difficulty. 5.14 – Attorneys Byrd & Adatto: Covered major legal trends including compounding pharmacy scrutiny, the evolving legal landscape around non-competes, and internal practice exits. 5.15 – Dr. Jude Pierre (Pt. 2): Discussed optimizing workflow through scribes, practice innovation via Medicare Advantage, and financial/lifestyle balance to avoid physician burnout. 5.16 & 5.17 – Cory Kleinschmidt: Provided a comprehensive look at locum tenens work for physicians—ideal for both early-career flexibility and late-career freedom—including licensing, contract tips, what to look for in an agency, forming LLCs for tax purpose and more. 5.18 – Drs. Mark Figgie & Joel Press: Shared a mentorship model from HSS that helps young physicians with career planning, finances, wellness, and leadership development. 5.19 – Bob Goettling: Introduced ESOPs (Employee Stock Ownership Plans) as an innovative, tax-efficient practice exit strategy increasingly relevant in the medical space. Learn more, including additional show notes, links, and detailed key takeaways, by visiting physicianswealthpodcast.com. Click here to get your FREE copy of our latest book, Wealth Strategies for Today's Physician!
Today's episode is kind of an Overtime / Ask The Sports Docs crossover. One of the PTs that Ashley works closely with asked her why some patients do well after ACL surgery and some don't fare as well, despite the surgery being identical in terms of technique, graft choice, post-op protocol etc. An article was just published in AJSM this month looking at this, specifically investigating factors that impact outcomes after ACL reconstruction. The article that we are reviewing today is titled “Primary Anterior Cruciate Ligament Reconstruction in Level 1 Athletes: Factors Associated With Return to Play, Reinjury, and Knee Function at 5 Years of Follow-up.” This level 2 cohort study aimed to analyze the outcomes of primary ACLR in level 1 athletes and identify preop and intraop factors associated with RTP, ipsilateral ACL reinjury, contralateral ACL injury, and IKDC score at 5 years post-op.** We have also been chatting about this episode offline and discussed an article that was recently published looking at preoperative grit scores and postoperative range of motion after ACL reconstruction. Grit score is another objective measurement that we can obtain preoperatively and perhaps use to guide intervention during post-op recovery. We actually did an Overtime episode looking at the impact of grit scores on post-op outcomes after ACL reconstruction. That is episode #53 if you want to check it out! But today's second article is titled “Higher Grit Scores Are Associated With Earlier Increases in Knee Flexion Following Anterior Cruciate Ligament Reconstruction With Meniscus Repair in Pediatric Patients.” It was published in the April 2023 issue of the Journal of Pediatrics. Pete Fabricant and his team at HSS found that patients with grit scores below the 50th percentile undergoing ACLR + meniscus repair have 5 degrees less total ROM at 3 months compared with those with high grit scores. Though 5 degrees might not seem like a lot, quicker motion recovery in patients with high grit may be a leading indicator of these patients likelihood to achieve other post-op milestones and meet criteria for RTS more quickly. This obvious needs future study to see how grit impacts other factors like strength gains, passing RTP assessments etc.
On this episode of the HindmanCast we go back in time to the late 1950s as we catch up with former HSS Bookmobile operator and Recreation Director, Loren Kramer. Our Archive Recovery Director, Sarah Insalaco recently discovered the work of Loren while exploring the archives and was able to make contact with him to get him on the show! Don't miss the discussion about this fascinating piece of HSS history!
What if your back pain is more than just physical? Dr. Stephen Thorp, MD — also known as “The Back Doctor” — joins The Council of Dude to explore spine health, performance, recovery, and the deeper messages our bodies send us when we're out of alignment. Stephen is a double board-certified, fellowship-trained physician who studied at Yale, Weill Cornell, HSS, and Sloan Kettering. He currently practices in Westchester County, NY, helping athletes and everyday folks move and live better. This one's about posture, pain, and purpose. Don't miss it.
On this episode of DGTL Voices, Ed interviews Lou Shapiro, CEO Emeritus of HSS. Ed and Lou discuss the importance of values, gratitude, and a helper's mindset in leadership. Lou shares his insights on creating a successful organizational culture, and his current endeavors post-retirement. "Lead with your heart, brain, and soul."
In this episode of the Wealth Planning for the Modern Physician podcast, host David Mandell sits down with two highly respected medical leaders—Dr. Mark Figgie, Chief Emeritus of the Surgical Arthritis Service at the Hospital for Special Surgery (HSS), and Dr. Joel Press, Physiatrist-in-Chief at HSS—to explore their personal and professional journeys in medicine. Dr. Press shares how his diverse early experiences led him to physiatry, while Dr. Figgie recounts his balance between science, business, and a lifelong pursuit of education, including earning an MBA during his fellowship. The conversation shifts into a discussion of mentorship at the Hospital for Special Surgery, where both physicians have played key roles in developing a cross-disciplinary mentorship model to support younger doctors. Their focus extends beyond clinical guidance to include career development, personal financial planning, and wellness—areas often overlooked in traditional medical training. This approach fosters institutional collaboration and a stronger culture at HSS. Finally, the episode dives into physicians' relationships with industry. Dr. Figgie offers candid advice on contracts, intellectual property rights, and ethical considerations when working with device manufacturers. He emphasizes the importance of legal review and staying true to what benefits patients. Dr. Press adds insight into personal financial trust, suggesting that doctors build a "board of directors" for trusted guidance. The episode closes with a preview of future initiatives aimed at supporting physicians earlier in their careers through financial education and mentorship. Key Insights: Dr. Press discovered physiatry through a unique summer program, showing the value of early exposure to diverse specialties. Dr. Figgie pursued an MBA during fellowship, believing in the power of financial literacy for physicians. Mentorship at HSS now includes financial, administrative, and personal development components—not just clinical. A cross-specialty mentorship program allows different departments (e.g., orthopedics and radiology) to learn from one another. Many young physicians lack basic financial planning tools, leading to under-preparedness later in their careers. HSS has created a repository of recorded educational sessions covering mortgages, insurance, investing, and more. Dr. Figgie cautions against blindly signing industry contracts without legal review, especially when IP is involved. Relationships with medical device companies often include consulting, design input, or teaching—but require transparency. Dr. Press emphasizes the importance of building a trusted "personal board of directors" to help with life and career decisions. Future initiatives at HSS may include subsidized financial checkups for new physicians to kickstart long-term planning. Learn more, including additional show notes, links, and detailed key takeaways, by visiting physicianswealthpodcast.com. Click here to get your FREE copy of our latest book, Wealth Strategies for Today's Physician!
In this episode of HSS Presents, Dr. Kyle Kunze, chief orthopedic surgery resident at Hospital for Special Surgery, sits down with Dr. Ayoosh Pareek, orthopedic surgeon and Medical Director of Artificial Intelligence and Digital Health at HSS. Together, they explore the evolving role of AI in musculoskeletal care—from automating clinical workflows to enhancing diagnostic capabilities—and discuss how physicians are uniquely positioned to guide ethical and effective AI integration into patient care. The conversation spans current applications such as ambient scribe technology, predictive analytics, and AI-driven patient triage, as well as long-term possibilities like agentic AI and robotics. Drs. Kunze and Pareek also examine challenges around trust, explainability, and research integrity, offering insights into how clinicians and data scientists can collaborate to ensure AI tools are both safe and impactful. This episode previews the upcoming special edition of HSS Journal, guest edited by Dr. Kunze, focused on artificial intelligence and digital health in orthopedic practice.
Today's episode is going to focus on management of patellar instability – including nonsurgical treatment, MPFL reconstruction techniques and the addition of other procedures including trochleoplasty and osteotomies. We are joined today by two outstanding guests! Dr. Miho Tanaka is a Professor of Orthopedic Surgery at Harvard Medical School and the Director of the women sports medicine program at Mass General Brigham. She is also the head team physician for the New England Revolution and team physician for the Boston Red Sox, Boston ballet and Boston Glory.Dr. Beth Shubin Stein is an orthopaedic surgeon at the Hospital for Special Surgery and Professor of Orthopaedic Surgery at Weill Cornell Medical College. She is also the Co-Director of the women's sports medicine center at HSS and the Director of the Patellofemoral Center at HSS.So, without further ado, let's get to the Field House!
In this episode of HSS Presents, Dr. Samuel A. Taylor, M.D., a sports medicine and shoulder surgery specialist at HSS, hosts an in‐depth discussion on long head of biceps tendon injuries with his esteemed colleagues—mentor Dr. Stephen J. O'Brien, MD, MBA, Dr. James "Beamer" Carr II, and Dr. Sri Pinnamaneni, M.D. The panel delves into the complexities of diagnosing and managing pathology within the biceps–labrum complex. They share personal anecdotes and historical insights that trace the evolution of treatment. Emphasizing that no imaging study can replace a thorough physical exam, the experts detail essential maneuvers and discuss the utility of ultrasound-guided diagnostic injections to pinpoint the true pain generator. With lively debate over whether to be a “biceps lover” or a “biceps killer,” this conversation offers valuable clinical pearls and practical strategies for shoulder surgeons navigating one of the most nuanced areas in sports medicine.
Our guest this week is an expert in the use of words as a surf columnist, writer, editor, digital marketer, copywriter and editorial content creator, with a Bachelor of Arts in English, we are sure to be corrected throughout this interview for the incorrect use of words!! Before becoming the Editor in Chief of Surfer Magazine, launching Red Bull Surfing, and working for folks like ESPN and NBC, he was writing Surfline's reports and recording their 976-SURF phone reports in the late ‘90s. He has been the Senior Editor for The Surfers Journal and World Surf League. He's been a copywriter for Quiksilver, Roxy, and Rip Curl. We welcome to the show (an HSS alumni) Mr. Jake Howard.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, Mary E. Cassai, MPA, RN, Executive Vice President and Chief Operating Officer at Hospital for Special Surgery, shares insights on HSS's commitment to excellence, innovation, and accessibility in musculoskeletal care. She discusses recent achievements, future growth strategies, and how she is evolving as a leader in an ever-changing healthcare landscape.
© 2020-2026 Ivy Podcast Discovery LLC
